The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection

Shih-Min Wang, I. Chun Chen, Yu Ting Liao, Ching-Chuan Liu

研究成果: Article

5 引文 (Scopus)

摘要

Background: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. Objective: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. Study Design: Patients <18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. Results: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4 +CD25+Foxp3+ and CD4+Foxp3 + T cells compared with patients with HFMD or BE. The expression frequency of CD4-CD8- was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4+Foxp3+ increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. Conclusions: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.

原文English
文章編號e102025
期刊PloS one
9
發行號7
DOIs
出版狀態Published - 2014 七月 10

指紋

Enterovirus Infections
Enterovirus
T-cells
Milrinone
Neurology
cyclic AMP
Regulatory T-Lymphocytes
Cyclic AMP
autonomic nervous system
Pulmonary Edema
T-lymphocytes
edema
Autonomic Nervous System
hand, foot and mouth disease
lungs
Hand, Foot and Mouth Disease
brain stem
Encephalitis
encephalitis
infection

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

引用此文

@article{1fcc92adb5b2432186f37c9e8b55fdab,
title = "The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection",
abstract = "Background: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. Objective: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. Study Design: Patients <18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. Results: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4 +CD25+Foxp3+ and CD4+Foxp3 + T cells compared with patients with HFMD or BE. The expression frequency of CD4-CD8- was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4+Foxp3+ increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. Conclusions: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.",
author = "Shih-Min Wang and Chen, {I. Chun} and Liao, {Yu Ting} and Ching-Chuan Liu",
year = "2014",
month = "7",
day = "10",
doi = "10.1371/journal.pone.0102025",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection. / Wang, Shih-Min; Chen, I. Chun; Liao, Yu Ting; Liu, Ching-Chuan.

於: PloS one, 卷 9, 編號 7, e102025, 10.07.2014.

研究成果: Article

TY - JOUR

T1 - The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection

AU - Wang, Shih-Min

AU - Chen, I. Chun

AU - Liao, Yu Ting

AU - Liu, Ching-Chuan

PY - 2014/7/10

Y1 - 2014/7/10

N2 - Background: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. Objective: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. Study Design: Patients <18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. Results: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4 +CD25+Foxp3+ and CD4+Foxp3 + T cells compared with patients with HFMD or BE. The expression frequency of CD4-CD8- was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4+Foxp3+ increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. Conclusions: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.

AB - Background: Brainstem encephalitis (BE) and pulmonary edema (PE) are notable complications of enterovirus 71 (EV71) infection. Objective: This study investigated the immunoregulatory characterizations of EV71 neurological complications by disease severity and milrinone treatment. Study Design: Patients <18 years with virologically confirmed EV71 infections were enrolled and divided into 2 groups: the hand, foot, and mouth disease (HFMD) or BE group, and the autonomic nervous system (ANS) dysregulation or PE group. Cytokine and cyclic adenosine monophosphate (cAMP) levels, and the regulatory T cell (Tregs) profiles of the patients were determined. Results: Patients with ANS dysregulation or PE exhibited significantly low frequency of CD4 +CD25+Foxp3+ and CD4+Foxp3 + T cells compared with patients with HFMD or BE. The expression frequency of CD4-CD8- was also significantly decreased in patients with ANS dysregulation or PE. Among patients with ANS dysregulation or PE, the expression frequency of CD4+Foxp3+ increased markedly after milrinone treatment, and was associated with reduction of plasma levels IL-6, IL-8 and IL-10. Plasma concentrations of cAMP were significantly decreased in patients with ANS dysregulation or PE compared with patients with HFMD or BE; however, cAMP levels increased after milrinone treatment. Conclusions: These findings suggested decreased different regulatory T populations and cAMP expression correlate with increased EV71 disease severity. Improved outcome after milrinone treatment may associate with increased regulatory T populations, cAMP expression and modulation of cytokines levels.

UR - http://www.scopus.com/inward/record.url?scp=84904262656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904262656&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0102025

DO - 10.1371/journal.pone.0102025

M3 - Article

C2 - 25010330

AN - SCOPUS:84904262656

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e102025

ER -